ergebnisse der wsg adapt hr /her2- studie
Published 3 years ago • 16 plays • Length 14:03Download video MP4
Download video MP3
Similar videos
-
15:24
#asco21 - oleg gluz: wsg-adapt hr /her2- ergebnisse in der hochrisikogruppe
-
1:59
adapt: de-escalated neoadjuvant pertuzumab trastuzumab with or without paclitaxel in hr-/her2 ebc
-
19:16
treatment selection for patients with equivocal her2 status and in luminal versus her2 enriched ...
-
4:17
gluz: final analysis of wsg-adapt her2 /hr
-
3:46
outcomes from adapt-hr-/her2 evaluating dual her2 blockade
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
51:40
optimizing treatment options for her2 / er breast cancer using models of endocrine resistance
-
7:06
esmo 2023 | dato dxd - 2. ergebnisse der tropion breast01 studie bei metastasiertem brustkrebs
-
1:01:35
her2 treatment
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
1:20
phase ii adapt trial in patients with her2 and hr early breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
1:41
adapt trial: endocrine ribociclib vs. chemotherapy in hr /her2- early breast cancer
-
1:19
dr. yee on phase ii adapt trial results for her2 /hr breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
4:55
the impact of biomarkers on pcr and survival in wsg adapt tp
-
2:18
dr. hershman on the use of endocrine therapy in premenopausal hr /her2- breast cancer
-
3:49
unmet needs in r/r her2 metastatic breast cancer
-
0:49
systemic therapies shown to be effective in her2-positive breast cancer
-
7:34
first-line therapy for hr-positive, her2-negative, mbc
-
5:45
her2-targeted therapy for breast cancer (english)